FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN)

CUSIP: 35655L107

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / SPONSORED ADS
Total 13F shares
38,057,795
Share change
+109,510
Total reported value
$18,192,005
Price per share
$0.48
Number of holders
16
Value change
+$49,718
Number of buys
6
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 35655L107?
CUSIP 35655L107 identifies FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) as of Q4 2022

As of 31 Dec 2022, FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,057,795 shares. The largest 10 holders included Syncona Portfolio Ltd, EVENTIDE ASSET MANAGEMENT, LLC, CHI Advisors LLC, TFG Asset Management GP Ltd, UBS Group AG, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, HARBOR CAPITAL ADVISORS, INC., Thrivent Financial for Lutherans, and FEDERATED HERMES, INC.. This page lists 16 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.